0 0
Advertisements
Read Time:8 Second

The US Food and Drug Administration has authorized a new monoclonal antibody treatment that seems to work against the Omicron variant of the virus that causes Covid-19.

About Post Author

Happy
0 0 %
Sad
0 0 %
Excited
0 0 %
Sleepy
0 0 %
Angry
0 0 %
Surprise
0 0 %